Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential Hypertension

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.

Also called NCT03945305

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
  • Yi Yang Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03945305
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT03945305. Randomized; single masking; primary purpose treatment. Start 2023-11-25 (actual); primary completion 2026-07-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential Hypertension
Condition
Essential Hypertension
Intervention (Device)
Patients are treated with previous antihypertensive treatment plus remote ischemic conditioning.
Intervention (Other)
Previous antihypertensive treatment
Lead sponsor
Yi Yang (class: other)

Record details

Record id
cardio:ct-nct03945305
Content hash
684bf73977d2b39ad9b0ee83c54cbf34a5f81d62172f2d32526326ff62d10bcd